Biogen Inc. buy Royal Bank of Canada
Start price
26.06.24
/
50%
€208.90
Target price
26.06.25
€296.81
Performance (%)
-13.00%
Price
09:30
€181.75
Summary
This prediction is currently active. The prediction for Biogen Inc. disappoints with a performance of -13.00%. This prediction currently runs until 26.06.25. The prediction end date can be changed by Royal_Bank_of_Canada at any time. Royal_Bank_of_Canada has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Biogen Inc. | -7.134% | -7.134% |
iShares Core DAX® | -5.630% | -5.765% |
iShares Nasdaq 100 | -8.559% | -13.005% |
iShares Nikkei 225® | -9.576% | -9.058% |
iShares S&P 500 | -6.631% | -7.103% |
Comments by Royal_Bank_of_Canada for this prediction
In the thread Biogen Inc. diskutieren
Biogen Inc. (NASDAQ: BIIB) had its "outperform" rating re-affirmed by analysts at Royal Bank of Canada. They now have a $317.00 price target on the stock.
Ratings data for BIIB provided by MarketBeat